Results 121 to 130 of about 17,963 (297)

Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma

open access: yesIndian Journal of Endocrinology and Metabolism, 2017
Background: Clinical relevance of association of cabergoline use for hyperprolactinemia and cardiac valvulopathy remains unclear. Objective: The aim of the study was to determine the prevalence of valvular heart abnormalities in patients taking ...
Shruti Khare   +6 more
doaj   +1 more source

MicroRNA-93 mediates cabergoline-resistance by targeting ATG7 in prolactinoma.

open access: yesJournal of Endocrinology, 2019
To date, the management of dopamine agonist (DA)-resistant prolactinomas remains a major clinical problem. Previously, we determined that miRNA-93 expression increases in DA-resistant prolactinomas; however, the role of miRNA-93 in the DA resistance ...
Zerui Wu   +10 more
semanticscholar   +1 more source

New Pituitary Adenoma Classification System to Individualise Management and Improve Long‐Term Prognosis

open access: yes
Clinical Endocrinology, Volume 102, Issue 2, Page 147-148, February 2025.
Gudmundur Johannsson   +2 more
wiley   +1 more source

Transanal endoscopic microsurgery: The first attempt in treatment of rectal amyloidoma [PDF]

open access: yes, 2015
Localized amyloidosis is characterized by amyloid protein deposition restricted to one organ or tissue without systemic involvement. Gastrointestinal manifestations of localized amyloidoma are unusual, which makes amyloidoma restricted to the rectum a ...
George, Virgilio, Sharma, Richa
core   +1 more source

Prolactinoma

open access: yesRadiopaedia.org, 2021
Henry Knipe, Frank Gaillard
semanticscholar   +1 more source

The Balance of PI3K and ERK Signaling Is Dysregulated in Prolactinoma and Modulated by Dopamine.

open access: yesEndocrinology, 2018
Prolactin-secreting adenomas, or prolactinomas, cause hypogonadism, osteoporosis, and infertility. Although dopamine agonists (DAs) are used clinically to treat prolactinoma and reduce prolactin secretion via cAMP inhibition, the precise mechanism by ...
Allyson K. Roof   +6 more
semanticscholar   +1 more source

Malignant Prolactinoma Discovered by D2 Receptor Imaging [PDF]

open access: bronze, 2000
Patrick Pétrossians   +5 more
openalex   +2 more sources

Etiology, functional status and short term outcome of patients with pituitary lesions. An experience from a developing country [PDF]

open access: yes, 2009
OBJECTIVE: To describe the etiology, functional status and short term outcome of patients with pituitary lesions (PL). METHODS: Brain or pituitary MRI reports of 3753 patients were analyzed for PL over the period of 2000 to 2007, done at the Aga Khan ...
Haq, Mansoor Ul   +5 more
core   +1 more source

A broader outlook is required to stage and classify pituitary neoplasms for patient care

open access: yes
Brain Pathology, Volume 35, Issue 1, January 2025.
Shlomo Melmed   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy